Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 2 of 2 entries
View as:
Phase: N/A
Priority: Normal
Start: 04/22/24
End: 06/30/26
Due: 06/30/27
Phase: N/A
Priority: Normal
Start: 05/06/24
End: 05/31/26
Due: 05/31/27
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Neoadjuvant IMRT Combined With Camrelizumab and Apatinib for Resectable HCC With PVTT | NCT06349317 | Yongyi Zeng | user2@example.com | None | 2024-04-22 | 2026-06-30 | 2027-06-30 | - | - | 2025-07-14 |
| Neoantigen Vaccine Plus Capecitabine as Adjuvant Therapy for Intrahepatic Cholangiocarcinoma After Radical Resection | NCT06406816 | Yongyi Zeng | user2@example.com | None | 2024-05-06 | 2026-05-31 | 2027-05-31 | - | - | 2025-07-14 |